LAP3 and colorectal cancer: Although these divergent influences on CRC prognosis suggest different acting roles for these serine peptidases in this disease, the expression and activity increases of these peptidases in neoplastic and preneoplastic tissues should be taken into account when designing new therapeutic approaches for colorectal cancer.